Skip to main content

Advertisement

Table 2 Comparison of treatment regimens between groups

From: APACHE-II score for anti-tuberculosis tolerance in critically ill patients: a retrospective study

Treatment characteristic Drug withdrawal group (n = 147) Therapy completion group (n = 173) P
Isoniazid (H) and rifampicin (R) 0.27
 Neither H nor R used 6 (4.1%) 15 (8.7%)  
 H used but R not used 48 (32.7%) 54 (31.2%)
 Both H and R used 90 (61.2%) 104 (60.1%)
Use of HRZE regimen 0.84
 HRZE regimen used 90 (61.2%) 104 (60.1%)  
 Non-HRZE regimen used 57 (38.8%) 69 (39.9%)
Number of drugs used 0.21
  ≤ 2 8 (5.4%) 17 (9.8%)  
 3 41 (27.9%) 49 (28.3%)
 4 57 (38.8%) 73 (42.2%)
 5–6 41 (27.9%) 34 (19.7%)
  1. Data are presented as n (%). HRZE: isoniazid (H), rifampicin (R), pyrazinamide (Z) and ethambutol (E)